NO20061138L - Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi - Google Patents

Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi

Info

Publication number
NO20061138L
NO20061138L NO20061138A NO20061138A NO20061138L NO 20061138 L NO20061138 L NO 20061138L NO 20061138 A NO20061138 A NO 20061138A NO 20061138 A NO20061138 A NO 20061138A NO 20061138 L NO20061138 L NO 20061138L
Authority
NO
Norway
Prior art keywords
glycemia
hyperglycemia
prevention
treatment
stabilize
Prior art date
Application number
NO20061138A
Other languages
English (en)
Inventor
Lucien Lesaffre
Original Assignee
Lesaffre & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lesaffre & Cie filed Critical Lesaffre & Cie
Publication of NO20061138L publication Critical patent/NO20061138L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Den foreliggende oppfinnelse angår behandlingen og forebyggingen av hyperglykemi og stabiliseringen av glykemi.
NO20061138A 2003-08-11 2006-03-09 Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi NO20061138L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03018222 2003-08-11
EP03020253 2003-09-08
PCT/EP2004/008933 WO2005021015A1 (fr) 2003-08-11 2004-08-10 Ecorces de levures pour le traitement ou la prevention de l’hyperglycemie ou pour la stabilisation de la glycemie

Publications (1)

Publication Number Publication Date
NO20061138L true NO20061138L (no) 2006-05-10

Family

ID=34276722

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061138A NO20061138L (no) 2003-08-11 2006-03-09 Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi

Country Status (17)

Country Link
US (2) US7459159B2 (no)
EP (1) EP1663266B1 (no)
JP (2) JP4808619B2 (no)
KR (1) KR101076209B1 (no)
AU (1) AU2004267928B2 (no)
BR (1) BRPI0413481A (no)
CA (1) CA2534791C (no)
DK (1) DK1663266T3 (no)
EA (1) EA009677B1 (no)
ES (1) ES2405934T3 (no)
MA (1) MA28072A1 (no)
MX (1) MXPA06001741A (no)
NO (1) NO20061138L (no)
NZ (1) NZ545594A (no)
PL (1) PL1663266T3 (no)
PT (1) PT1663266E (no)
WO (1) WO2005021015A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006117566A (ja) * 2004-10-20 2006-05-11 Asahi Breweries Ltd 糖代謝改善剤
JP2007195444A (ja) * 2006-01-26 2007-08-09 Asahi Food & Healthcare Ltd ダイエット飲食品
US20100008877A1 (en) * 2006-08-24 2010-01-14 Kirin Holdings Kabushiki Kaisha Composition for improving skin condition
JP5238166B2 (ja) * 2007-02-02 2013-07-17 株式会社ヤクルト本社 インターロイキン１２産生抑制剤
FR2919187B1 (fr) * 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2949064B1 (fr) * 2009-08-14 2011-10-07 Lesaffre & Cie Nouvelles compositions destinees a la prevention et/ou au traitement du diabete
FR2978967B1 (fr) * 2011-08-09 2020-03-20 Lesaffre Et Compagnie Ecorces de levure enrichies en vitamine d2, compositions les contenant, leur procede de preparation, leurs utilisations et dispositif permettant la mise en oeuvre du procede
MD4216C1 (ro) * 2012-08-15 2013-11-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Tulpină de drojdii Saccharomyces cerevisiae - producătoare de manani
EP3443849A4 (en) * 2016-04-14 2020-01-15 TableMark Co., Ltd. Food composition or combination for lowering blood glucose level or reducing gi value
US20190307823A1 (en) * 2016-05-17 2019-10-10 KOHJIN Life Sciences Co., Ltd. Yeast extract having diabetes prevention effect
IT201600069379A1 (it) * 2016-07-04 2018-01-04 Prosol S P A Composizione sostanzialmente costituita da pareti cellulari di lievito e procedimento per la sua preparazione
PL3685681T3 (pl) 2019-01-23 2024-10-21 Lesaffre Et Compagnie Produkt drożdżowy i zawierająca go kompozycja do zastosowania jako środek prebiotyczny

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
JPS61167622A (ja) * 1985-01-22 1986-07-29 Asahi Breweries Ltd 糖尿病コントロ−ル剤
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
JP3647042B2 (ja) * 1993-12-28 2005-05-11 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 可溶性繊維に富むシリアル食品
DE4413023A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Gewinnung eines Faktors mit insulinartiger Wirkung aus Hefeextrakt
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
US5773426A (en) * 1996-06-07 1998-06-30 Masaki Shirota Proteoglucan and antidiabetic drug thereof
EP0928196B1 (en) * 1996-09-25 2003-12-17 Gracelinc Limited Beta-glucan products and extraction processes from cereals
DE19835767A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae
FR2800076B1 (fr) * 1999-10-22 2003-11-14 Lesaffre & Cie Mannoproteines solubles
DE60135658D1 (de) * 2000-07-03 2008-10-16 Granate Seed Ltd In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
TWI300714B (en) * 2001-04-27 2008-09-11 Ajinomoto Kk Immunopotentiators
FR2825004B1 (fr) * 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk MEDICINE AGAINST DIABETES
US20030118989A1 (en) * 2001-12-21 2003-06-26 Carsten Rosenow Differential isolation of cellular content for biological assays

Also Published As

Publication number Publication date
US7459159B2 (en) 2008-12-02
CA2534791A1 (fr) 2005-03-10
DK1663266T3 (da) 2013-05-13
BRPI0413481A (pt) 2006-10-17
MA28072A1 (fr) 2006-08-01
JP4808619B2 (ja) 2011-11-02
AU2004267928A1 (en) 2005-03-10
EA009677B1 (ru) 2008-02-28
EA200600402A1 (ru) 2006-08-25
PT1663266E (pt) 2013-04-30
JP2007501829A (ja) 2007-02-01
EP1663266A1 (fr) 2006-06-07
US20060257422A1 (en) 2006-11-16
KR20060037432A (ko) 2006-05-03
KR101076209B1 (ko) 2011-10-24
WO2005021015A1 (fr) 2005-03-10
EP1663266B1 (fr) 2013-02-20
US20090022758A1 (en) 2009-01-22
NZ545594A (en) 2009-09-25
PL1663266T3 (pl) 2013-07-31
CA2534791C (fr) 2014-10-28
JP2011178794A (ja) 2011-09-15
MXPA06001741A (es) 2006-05-12
AU2004267928B2 (en) 2010-10-21
ES2405934T3 (es) 2013-06-04

Similar Documents

Publication Publication Date Title
NO20055832L (no) Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme
CY1117346T1 (el) Κυτταρα που συνεκφραζουν μια σουλφαταση και ενα ενζυμο παραγωγης c-φορμυλογλυκινης και μεθοδοι και χρησεις αυτων
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
DE60330485D1 (de) Zur behandlung von diabetes
ATE485366T1 (de) Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau
DE60312017D1 (de) Sulfonderivate zur hemmung von gamma-secretase
DK1768490T3 (da) Systemer og fremgangsmåder til ex-vivo-organpleje
ATE447574T1 (de) 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
EA200870019A1 (ru) Лактамовые соединения и способы их применения
DE60232245D1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
NO20075815L (no) Formuleringer og metoder for behandling av amyloidose
NO20050717L (no) Metode og sammensetninger for modulering av T hjelpe (TH) celleutvikling og funksjon
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
NO20055130L (no) Aminocykloheksyleter-forbindelser og deres anvendelse
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
TNSN06030A1 (en) Substituted thiazole-benzoisothiazole dioxide derivavites, method for the production thereof and use of the same
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
EA200600402A1 (ru) Клеточные стенки дрожжей для лечения или профилактики гипергликемии или для стабилизации уровня сахара в крови
WO2004033660A3 (en) Gene expression profiling from ffpe samples
EP1667685A4 (en) -QUINAZOLINE-POTASSIUM CHANNEL INHIBITORS
PT1603544E (pt) Tratamento de problemas intestinais com n-2,3,3-tetrametilbiciclo 2.2.2. heptan-2-amina
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application